Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is… Read more
Market Cap & Net Worth: Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ:LMRI) has a market capitalization of $125.09K ($125.09K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #40478 globally and #13128 in its home market, demonstrating a -11.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lumexa Imaging Holdings, Inc. Common Stock's stock price $13.04 by its total outstanding shares 9593 (9.59K).
Lumexa Imaging Holdings, Inc. Common Stock Market Cap History: 2025 to 2026
Lumexa Imaging Holdings, Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $177.47K to $125.09K (0.00% CAGR).
Lumexa Imaging Holdings, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lumexa Imaging Holdings, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LMRI by Market Capitalization
Companies near Lumexa Imaging Holdings, Inc. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to Lumexa Imaging Holdings, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Lumexa Imaging Holdings, Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Lumexa Imaging Holdings, Inc. Common Stock's market cap moved from $177.47K to $ 125.09K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $125.09K | -29.51% |
| 2025 | $177.47K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Lumexa Imaging Holdings, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $125.09K USD |
| MoneyControl | $125.09K USD |
| MarketWatch | $125.09K USD |
| marketcap.company | $125.09K USD |
| Reuters | $125.09K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.